IN BRIEF: Sensyne Health gets UK heath regulator boost
IN BRIEF: Sensyne Health gets UK heath regulator boost
Read moreWed, 25th Nov 2020 15:07
IN BRIEF: Sensyne Health gets UK heath regulator boost
Read more(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Friday that its 'MagnifEye' software application, which uses AI to automate the accurate reading and analysis of lateral flow diagnostic tests, has been granted special use authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA).
Read more(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year non-exclusive strategic research agreement (SRA) with the Royal Devon and Exeter NHS Foundation Trust, it announced on Friday.
Read moreTRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump
Read moreIN BRIEF: Sensyne signs deal with UK government to fund Covid tests
Read more(Sharecast News) - Clinical artificial intelligence (AI) technology company Sensyne Health has signed a £0.47m agreement with the Department of Health and Social Care, it announced on Friday, to conduct the second stage of a pilot study of its 'MagnifEye' technology for use with Covid-19 lateral flow diagnostic tests.
Read moreEXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma
Read more(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'SYNE-COV' machine learning algorithm for Covid-19 risk prediction has achieved regulatory approval for use in the UK.
Read moreTRADING UPDATES: 1Spatial expects full-year results ahead of forecasts
Read more(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed an exclusive licence and development agreement with Excalibur Healthcare Services, it announced on Tuesday, to apply Sensyne's 'MagnifEye' system for use with Excalibur's proprietary lateral flow rapid diagnostic tests across a range of indications, including its Covid-19 antigen test currently being marketed in the UK and Europe.
Read moreTRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat
Read moreEXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director
Read moreIN BRIEF: Sensyne Health Launches AI Algorithm For Patient Management
Read moreSensyne Health Interim Loss Widens But Boasts Of Commercial Progress
Read moreIN BRIEF: Sensyne Health Signs Long-Term Deal With NHS Trust
Read more